Latest: FDA Approves New Biosimilar for Oncology Treatment

Arintra Raises $21M to Expand Beyond Autonomous Medical Coding

0 Mins
What You Should Know: – Arintra, a provider of GenAI-native autonomous medical coding, has announced a $21M Series A funding round led by Peak XV Partners, with participation from Endeavor Health Ventures, Y Combinator, and other strategic investors. – The funding will be used to accelerate product development, grow the team, and establish a new ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago